HLA-ABC Antikörper
-
- Target Alle HLA-ABC Antikörper anzeigen
- HLA-ABC
-
Reaktivität
- Human, Rind (Kuh), Pavian, Cynomolgus, Cat, Affe, Makake, Spitzmaus
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HLA-ABC Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (IHC), ELISA
- Spezifität
- Recognizes an antigenic determinant shared among products of the human HLA A, B and C loci. Recognizes a conformational epitope, reacting with HLA class I alpha3 and alpha2 domains.
- Aufreinigung
- Protein G purified
- Endotoxin-Niveau
- Low Endotoxin
- Immunogen
-
Purified human tonsil lymphocyte membranes.
Type of Immunogen: Cells - Isotyp
- IgG2a
- Top Product
- Discover our top product HLA-ABC Primärantikörper
-
-
- Applikationshinweise
-
Approved: ELISA, Flo (1:50 - 1:100), IHC, IHC-Fr, IP
Usage: Suitable for use in ELISA, Flow Cytometry, Immunohistochemistry and Immunoprecipitation. Flow Cytometry: 1:50-1:100, 10 μL labels 10^6 cells in 100 μL. Immunohistochemistry: frozen sections. The applications listed have been tested for the unmodified form of this product. Other forms have not been tested. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7.4. No preservative added. Endotoxin Level: <0.01 EU/ug
- Konservierungsmittel
- Without preservative
- Handhabung
- Aliquot to Avoid repeated freezing and thawing.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
-
- Target
- HLA-ABC
- Andere Bezeichnung
- HLA-A/B/C (HLA-ABC Produkte)
- Synonyme
- HLAA antikoerper, major histocompatibility complex, class I, A antikoerper, HLA-A antikoerper
- Pathways
- T-Zell Rezeptor Signalweg, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-